RAFAEL HOLDINGS, INC. Deferred Tax Assets, Unrealized Losses on Trading Securities
RAFAEL HOLDINGS, INC. (RFL) had Deferred Tax Assets, Unrealized Losses on Trading Securities of $30.24 million as of 2023-07-31, per its 10-K/A filed 2024-12-20.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsUnrealizedLossesOnTradingSecurities · last filed 2024-12-20
- 2023-07-31: Deferred Tax Assets, Unrealized Losses on Trading Securities $30.24M.
- 2022-07-31: Deferred Tax Assets, Unrealized Losses on Trading Securities $31.85M.
| Period end | Deferred Tax Assets, Unrealized Losses on Trading Securities |
|---|---|
| 2023-07-31 | $30.24M 10-K/A · filed 2024-12-20 |
| 2022-07-31 | $31.85M 10-K · filed 2023-10-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |